chinese

A unique collection of 2755 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism；

A unique collection of 1147 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening；

A collection of 1246 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study；

A unique collection of 2051 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study;

A unique collection of 580 compounds derived from traditional Chinese medicines (TCMs) for promoting blood circulation and removing blood stasis.

A collection of 268 TCM monomers with anti-virus activity. An effective tool for drug development and pharmacological studies.

A collection of 382 TCM monomers with anti-colorectal activity. An effective tool for drug development and pharmacological studies.

A collection of 747 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening.

A unique collection of 4533 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen

A unique collection of 514 flavonoids can be used for high throughput and high content screening；

A unique collection of 1290 compounds from food as medicine for high throughput and high content screening;

A unique collection of 3048 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 534 compounds featuring natural product molecules derived from Miao medicine that can be used for high-throughput and high-content screening.